IL147890A0 - Pharmaceutical compositions containing pentafluorobenzenesulfonamide derivatives - Google Patents

Pharmaceutical compositions containing pentafluorobenzenesulfonamide derivatives

Info

Publication number
IL147890A0
IL147890A0 IL14789000A IL14789000A IL147890A0 IL 147890 A0 IL147890 A0 IL 147890A0 IL 14789000 A IL14789000 A IL 14789000A IL 14789000 A IL14789000 A IL 14789000A IL 147890 A0 IL147890 A0 IL 147890A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
pentafluorobenzenesulfonamide
derivatives
pentafluorobenzenesulfonamide derivatives
Prior art date
Application number
IL14789000A
Other languages
English (en)
Original Assignee
Tularik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tularik Inc filed Critical Tularik Inc
Publication of IL147890A0 publication Critical patent/IL147890A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Weting (AREA)
IL14789000A 1999-07-29 2000-07-27 Pharmaceutical compositions containing pentafluorobenzenesulfonamide derivatives IL147890A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14643699P 1999-07-29 1999-07-29
PCT/US2000/020763 WO2001008693A2 (en) 1999-07-29 2000-07-27 Combination therapy using pentafluorobenzenesulfonamide and platin compound

Publications (1)

Publication Number Publication Date
IL147890A0 true IL147890A0 (en) 2002-08-14

Family

ID=22517356

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14789000A IL147890A0 (en) 1999-07-29 2000-07-27 Pharmaceutical compositions containing pentafluorobenzenesulfonamide derivatives
IL147890A IL147890A (en) 1999-07-29 2002-01-29 Pharmaceutical preparations containing a history of pentafluorobenzene sulfonamide

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147890A IL147890A (en) 1999-07-29 2002-01-29 Pharmaceutical preparations containing a history of pentafluorobenzene sulfonamide

Country Status (16)

Country Link
US (1) US6355628B1 (xx)
EP (1) EP1206256B8 (xx)
JP (1) JP2003505513A (xx)
KR (1) KR100685059B1 (xx)
CN (1) CN1181819C (xx)
AT (1) ATE294574T1 (xx)
AU (1) AU775305B2 (xx)
CA (1) CA2380078C (xx)
DE (1) DE60019937T2 (xx)
DK (1) DK1206256T3 (xx)
ES (1) ES2241639T3 (xx)
IL (2) IL147890A0 (xx)
PT (1) PT1206256E (xx)
RU (1) RU2268054C2 (xx)
WO (1) WO2001008693A2 (xx)
ZA (1) ZA200200889B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA001367B1 (ru) * 1996-02-22 2001-02-26 Туларик, Инк. Пентафторбензолсульфонамиды и их аналоги
EP0939627B1 (en) * 1996-07-19 2003-09-10 Tularik, Inc. Pentafluorobenzenesulfonamides and analogs
EA003924B1 (ru) * 1998-09-23 2003-10-30 Туларик, Инк. Арилсульфонанилидмочевины
AU2002234165A1 (en) 2000-11-03 2002-05-27 Tularik, Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
US20050250854A1 (en) * 2000-11-03 2005-11-10 Amgen Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
FR2834641B1 (fr) * 2002-01-14 2005-04-22 Ct Regional De Lutte Contre Le Protection de la neurotoxicite de l'oxaliplatine par administration de calcium et de magnesium
CN1968685B (zh) * 2003-11-19 2014-05-14 张立新 互动药物的筛选
US10238831B2 (en) 2013-09-08 2019-03-26 Qool Therapeutics, Inc. Temperature measurement and feedback for therapeutic hypothermia
EP3261593B1 (en) 2015-02-23 2021-11-03 Qool Therapeutics, Inc. Systems and methods for endotracheal delivery of frozen particles
US11186549B2 (en) 2017-08-29 2021-11-30 Rutgers, The State University Of New Jersey Therapeutic indazoles
EP3684754A4 (en) * 2017-09-21 2021-06-02 Dalriada Therapeutics Inc. PENTAFLUOROPHENYL SULFONAMIDE COMPOUNDS, COMPOSITIONS AND ASSOCIATED USES

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1955207A (en) 1931-09-16 1934-04-17 Ig Farbenindustrie Ag Mothproofing agent
US2402623A (en) 1943-06-24 1946-06-25 Rohm & Haas Nu-nitroaryl haloarylsulphonamides
CH362688A (de) 1957-09-10 1962-06-30 Geigy Ag J R Verfahren zur Herstellung von neuen Arylsulfonarylamiden
GB1242057A (en) 1968-07-04 1971-08-11 Ici Ltd Derivatives of 4-hydroxytetrafluoropyridine and the use thereof as plant growth regulators
NL174644C (nl) 1970-04-13 1984-07-16 Minnesota Mining & Mfg Werkwijze ter bereiding van een herbicide verbinding; tevens werkwijze voor de bereiding van een preparaat met herbicide werking.
DE3623184A1 (de) 1986-07-10 1988-01-14 Kali Chemie Ag Verfahren zur herstellung von n-fluorsulfonamiden
US4883914A (en) 1987-08-17 1989-11-28 American Cyanamid Company Benzenesulfonyl carboxamide compounds useful as herbicidal agents
DE3804990A1 (de) 1988-02-18 1989-08-31 Basf Ag Herbizid wirksame, heterocyclisch substituierte sulfonamide
FR2645537B1 (fr) 1989-04-05 1994-03-04 Fabre Medicament Pierre Nouveaux sulfonamides derives d'acides benzocycliques ou benzoheterocycliques, leur preparation et leur application en therapeutique
FR2665440B1 (fr) 1990-07-31 1994-02-04 Lipha Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant.
US5189211A (en) 1990-08-01 1993-02-23 Taisho Pharmaceutical Co., Ltd. Sulfonamide derivatives
ATE167473T1 (de) 1990-08-20 1998-07-15 Eisai Co Ltd Sulfonamid-derivate
WO1996040629A1 (en) 1995-06-07 1996-12-19 Sugen, Inc. Tyrphostin-like compounds for the treatment of cell proliferative disorders or cell differentiation disorders
EA001367B1 (ru) 1996-02-22 2001-02-26 Туларик, Инк. Пентафторбензолсульфонамиды и их аналоги
EP0939627B1 (en) * 1996-07-19 2003-09-10 Tularik, Inc. Pentafluorobenzenesulfonamides and analogs
DK0932402T3 (da) * 1996-10-15 2004-11-08 Searle Llc Metode til anvendelse af cyclooxygenase-2-inhibitorer ved behandling og forebyggelse af neoplasi
TR199901703T2 (xx) * 1996-11-19 2000-07-21 G.D. Searle & Co. Siklooksijenaz-2 inhibit�rlerini anti-anjiyojenik ajanlar olarak kullanma y�ntemi.
US5773236A (en) 1997-04-25 1998-06-30 Molecule Probes, Inc. Assay for glutathiane transferase using polyhaloaryl-substituted reporter molecules
CA2335559A1 (en) * 1998-06-25 1999-12-29 Tularik Inc. Arylsulfonanilide phosphates
EA003924B1 (ru) * 1998-09-23 2003-10-30 Туларик, Инк. Арилсульфонанилидмочевины
WO2000035865A2 (en) * 1998-12-17 2000-06-22 Tularik Inc. Tubulin-binding agents
CO5170498A1 (es) * 1999-05-28 2002-06-27 Abbott Lab Biaril sulfonamidas son utiles como inhibidores de proliferacion celular

Also Published As

Publication number Publication date
JP2003505513A (ja) 2003-02-12
EP1206256B8 (en) 2005-06-29
EP1206256B1 (en) 2005-05-04
AU775305B2 (en) 2004-07-29
CA2380078C (en) 2008-05-06
CN1181819C (zh) 2004-12-29
IL147890A (en) 2007-07-04
DE60019937D1 (de) 2005-06-09
DK1206256T3 (da) 2005-08-15
KR100685059B1 (ko) 2007-02-22
RU2268054C2 (ru) 2006-01-20
CA2380078A1 (en) 2001-02-08
RU2002105374A (ru) 2004-01-10
PT1206256E (pt) 2005-09-30
WO2001008693A2 (en) 2001-02-08
EP1206256A2 (en) 2002-05-22
WO2001008693A3 (en) 2001-05-25
US6355628B1 (en) 2002-03-12
ZA200200889B (en) 2003-03-26
ES2241639T3 (es) 2005-11-01
AU6615200A (en) 2001-02-19
CN1367690A (zh) 2002-09-04
KR20020050225A (ko) 2002-06-26
DE60019937T2 (de) 2006-05-04
ATE294574T1 (de) 2005-05-15

Similar Documents

Publication Publication Date Title
GEP20033025B (en) 4,4-Biarylpiperidine Derivatives with Opioid Receptor Activity
DE60112609D1 (en) Pyrazolopyridine
TW200508214A (en) Novel compounds
PL367682A1 (en) Dolastatin 10 derivatives
TW200635923A (en) Tricyclic heterocycles, their manufacture and use as pharmaceutical agents
SE9904505D0 (sv) Novel compounds
HK1048990A1 (en) Novel compounds.
AU2002239348A1 (en) Pyrazolopyridine derivatives
PT1212312E (pt) Novos derivados de flavonas xantonas e cumarinas
IL147890A0 (en) Pharmaceutical compositions containing pentafluorobenzenesulfonamide derivatives
DE60001586D1 (de) Diphenyl-piperidin derivate
IL151200A0 (en) Tricyclic imidazopyridine prodrug derivatives and pharmaceutical compositions containing the same
AU6797298A (en) Halo-alkoxycarbonyl prodrugs
IL131407A0 (en) Tetrahydropyrido compounds medicaments containing the same and the use thereof
GEP20094801B (en) Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
IL151198A0 (en) Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same
HK1060558A1 (en) 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof.
AU2002248531A1 (en) Pyrazolopyriadine derivatives
TW200504051A (en) Novel acridine derivatives and their use as medicaments
WO2002039958A3 (en) Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
JO2199B1 (en) Replaced pyrrols
TR200200987T2 (tr) Kanser tedavisine yönelik,ornatılmış pirroller
TW200602329A (en) Novel diazine derivatives, their manufacture and use as pharmaceutical agents
EP1390027A4 (en) COMPOSITION WITH DEMETHYLCANTHARIDINE IN COMBINATION WITH PLATINUM-CONTAINING ANTI-VITAL AGENTS AND THEIR USE
TW200701980A (en) Benzylether derivatives, their manufacture and use as pharmaceutical agents

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed